PANTHERx Specialty Pharmacy, the industry leading independent national specialty pharmacy, has been selected by Paratek Pharmaceuticals, Inc. as a limited pharmacy network provider of its new once-daily oral antibiotic, Nuzyra™ (omadacycline). Nuzyra™...

PANTHERx Specialty Pharmacy, The Rare Disease Specialty Pharmacy®, unveiled a new, sophisticated and modern brand identity today while simultaneously announcing a new, state-of-the-art third location. This past year. PANTHERx continued to grow and innovate,...

PANTHERx® Specialty Pharmacy, THE Rare Disease Specialty Pharmacy®, announces the expansion of its oncology franchise to include Precision Medicine. PANTHERx’s focus on rare and devastating diseases now extends to the full complement of oncology medications...

PANTHERx® Specialty Pharmacy, THE Rare Disease Specialty Pharmacy®, announced the addition of industry veteran Susan Faust to its executive leadership team as Senior Vice President and Head of Markets. In this role, Faust will be responsible for leading...

PANTHERx® Specialty Pharmacy, THE Rare Disease Specialty Pharmacy®, announced that it has been selected by Insmed Incorporated to distribute ARIKAYCE® (amikacin liposome inhalation suspension), the first and only therapy specifically indicated for the...

PANTHERx® Specialty Pharmacy, THE Rare Disease SP®, announces that is has been named 2018-2019 Specialty Pharmacy of the Year by the National Association of Specialty Pharmacy (NASP). The prestigious award was presented by the NASP President at the sixth...